Statement Regarding IRIDEX/Topcon Announcement

A personal statement from Nick Fitrzyk

“I am proud to have introduced the IRIDEX portfolio into the UK nearly three decades ago and I am delighted our strong association with the company is being maintained. The momentum gained in the Glaucoma arena with the introduction of the Cyclo G6™ providing MicroPulse® Transscleral Laser Therapy (TLT) is most encouraging and particularly relevant as we are currently in the middle of World Glaucoma Week.
My thanks go to the wonderful team I am fortunate to now have beside me in the UK and also a shout out to Franz Weingartner and Jim Mercereau, two gentlemen from IRIDEX, present and past, who have greatly assisted us here directly in the UK”.

Nick Fitrzyk
Managing Director

CYCLO G6™ G-Probe™

The patented CYCLO G6™ G-Probe™ device is used to deliver laser energy for the treatment of glaucoma.